George Adi Mor

Insider activity · 24 months2 buys0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 2 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (2 ops.)

€17k

▼ Sales (2 ops.)

€690k

Latest filing published 01 Jun 2026 for Chemomab Therapeutics Ltd., €8,610. Read the official filing

Filing timeline

BuySale

George Adi Mor

Insider track record

Disclosed buys

Disclosed sells

Signal history

Closed purchases

Market purchases

Positive at T+90

100%

Median T+90

+56.3%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Chemomab Therapeutics Ltd. 2 purchases · last 01 Jun 2026

Since each purchase

Chemomab Therapeutics Ltd.
Filed 01 Jun 2026 · 139 days ago · €8,610
-19.5%
Entry US$1.74 · Close 08 Oct 2026 US$1.40

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

George Adi Mor: trading record in brief

George Adi Mor appears in our data through filings on Chemomab Therapeutics Ltd. shares, published by SEC (Form 4). Over a trading history stretching from 16 November 2022 to 29 May 2026, the count stands at 6 filings.

On the open market, the record shows 2 purchases worth €17k and 2 sales worth €690k. Sales outweigh purchases by €673k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2026: 2 purchases and no sales on the market.

The record was last updated on 1 June 2026 with an open-market purchase (€8,610) in Chemomab Therapeutics Ltd. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.